We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.93%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.7B
AUM Growth
+$329M
Cap. Flow
-$710M
Cap. Flow %
-4.25%
Top 10 Hldgs %
19.03%
Holding
2,687
New
132
Increased
900
Reduced
1,002
Closed
108

Top Buys

Rank Stock Value
1
PGR icon
Progressive
PGR
+$232M
2
BNL icon
Broadstone Net Lease
BNL
+$66.5M
3
APH icon
Amphenol
APH
+$64M
4
SNPS icon
Synopsys
SNPS
+$46.8M
5
XLNX
Xilinx Inc
XLNX
+$46.5M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$78M
2
KEYS icon
Keysight
KEYS
+$69.7M
3
ADP icon
Automatic Data Processing
ADP
+$68.4M
4
CSCO icon
Cisco
CSCO
+$60.5M
5
OMC icon
Omnicom Group
OMC
+$52.8M

Sector Composition

Rank Sector Weight
1 Technology 23.23%
2 Healthcare 13.49%
3 Financials 11.88%
4 Consumer Discretionary 9.14%
5 Industrials 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTLE
2401
DELISTED
Vital Energy
VTLE
$1K ﹤0.01%
156
VYGR icon
2402
Voyager Therapeutics
VYGR
$189M
$1K ﹤0.01%
+177
New +$2.08K
WBS icon
2403
Webster Financial
WBS
$12.5B
$1K ﹤0.01%
41
WLK icon
2404
Westlake Corp
WLK
$9.19B
$1K ﹤0.01%
19
WMK icon
2405
Weis Markets
WMK
$1.92B
$1K ﹤0.01%
26
WOLF icon
2406
Wolfspeed
WOLF
$1.24B
$1K ﹤0.01%
18
WSBF icon
2407
Waterstone Financial
WSBF
$370M
$1K ﹤0.01%
125
WSR
2408
DELISTED
Whitestone REIT
WSR
$1K ﹤0.01%
313
+110
+54% +$716
ZYXI
2409
DELISTED
Zynex
ZYXI
$1K ﹤0.01%
83
MTUS icon
2410
Metallus
MTUS
$826M
$1K ﹤0.01%
418
LGF.A
2411
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$1K ﹤0.01%
+129
New +$1.11K
CUTR
2412
DELISTED
Cutera, Inc.
CUTR
$1K ﹤0.01%
62
BEST
2413
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$1K ﹤0.01%
30
SILK
2414
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$1K ﹤0.01%
+16
New +$873
NGM
2415
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$1K ﹤0.01%
104
+56
+117% +$1.02K
CPE
2416
DELISTED
Callon Petroleum Company
CPE
$1K ﹤0.01%
278
+92
+49% +$812
CBAY
2417
DELISTED
Cymabay Therapeutics
CBAY
$1K ﹤0.01%
+273
New +$1.46K
AYX
2418
DELISTED
Alteryx Inc
AYX
$1K ﹤0.01%
15
-400
-96% -$54.5K
MRTX
2419
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1K ﹤0.01%
10
SRC
2420
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$1K ﹤0.01%
+36
New +$1.25K
ITCL
2421
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$1K ﹤0.01%
512
FRGI
2422
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$1K ﹤0.01%
191
HARP
2423
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1K ﹤0.01%
9
-1
-10% -$144
RUTH
2424
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$1K ﹤0.01%
136
-165
-55% -$1.49K
LCI
2425
DELISTED
Lannett Company, Inc.
LCI
$1K ﹤0.01%
63

Similar funds

Glenmede Trust's Q3 2020 Portfolio in Review

As of Q3 2020, Glenmede Trust held 2,687 positions worth $16.7B, up 2% from $16.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glenmede Trust withdrew a net $710M in Q3 2020, closing 108 positions and reducing 1,002 holdings. Its most notable exit was IBERIABANK Corp, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Broadstone Net Lease worth $67.3M.

  • Glenmede Trust's largest Q3 2020 buy was Broadstone Net Lease: 4,009,897 shares worth $67.3M.
  • Glenmede Trust added most to Progressive in Q3 2020, an estimated $232M increase.
  • Glenmede Trust's biggest Q3 2020 reduction was Apple, cutting an estimated $78M.
  • Glenmede Trust fully exited IBERIABANK Corp in Q3 2020, selling an estimated $18.1M.
  • Glenmede Trust's ten largest holdings make up 19% of its $16.7B portfolio in Q3 2020.
  • Glenmede Trust opened 132 new positions and closed 108 in Q3 2020.
  • Glenmede Trust's portfolio value rose 2% quarter-over-quarter to $16.7B.

Based on Glenmede Trust's 13F filing for Q3 2020, filed 16 Nov 2020.